1.
Camejo-Martínez N, Strazzarino-Peluffo N, Amarillo-Hernández D, Castillo-Leska C, Krygier-Waltier G. Initial clinical experience with ribociclib in advanced HR+/HER2− breast cancer in Uruguay. Rev Med Inst Mex Seguro Soc [Internet]. 2026 May 6 [cited 2026 Nov. 13];64(3):e6704. Available from: https://revistamedica.imss.gob.mx/index.php/revista_medica/article/view/6704